CCL18 upregulation has been reported in a number of diseases, including HIV infection, atherosclerosis, pulmonary fibrosis, T2D, and in various cancers like breast, cervical, lung, and ovarian [15, 66–68]. This evidence concerns the gene CCL18 and type 2 diabetes mellitus.